Research Article
Clinicopathological Comparison of Adenocarcinoma of Cervix and Endometrium Using Cell Cycle Markers: P16ink4a, P21waf1, and p27Kip1 on 132 Cancers
Table 1
Summary of the clinicopathological parameters in adenocarcinoma of the cervix (ECA) and adenocarcinoma of the endometrium (EMA).
| | Variables of ECA | Frequency (%) of ECA | Variables of EMA | Frequency (%) of EMA |
| | Age (years) | | Age (years) | | | <35 | 3 (7.5) | <50 | 28 (30.4) | | 35–54 | 22 (55.0) | 50–60 | 35 (38.0) | | ≥55 | 15 (37.5) | >60 | 29 (31.5) |
| | FIGO stage | | FIGO stage | | | I | 27 (57.5) | I | 50 (54.3) | | ll | 7 (17.5) | II | 13 (14.1) | | lll | 5 ((12.5) | lll | 13 (14.1) | | IV | 5 (12.5) | lV | 16 (17.4) |
| | Histology tumor differentiation | | Myometrial invasion | | | Well/moderate | 25 (62.5) | < | 45 (48.9) | | Poor and Special type | 15 (37.5) | > | 47 (51.1) |
| | Infiltration depth | | Histologic grade | | | Inner 2/3 | 13 (32.5) | G1 | 39 (42.4) | | Outer 1/3 or through | 27 (67.5) | G2 | 23 (25.0) | | | G3 | 30 (32.6) |
| | Tumor length | | Postmenopausal status | | | <20 mm | 11 (32.5) | Yes | 54 (58.7) | | >20 mm | 29 (67.5) | No | 38 (41.3) |
| | Tumor thickness | | | | | <5 mm | 4 (10.0) | | | | >5 mm | 36 (90.0) | | |
| | Infiltration to corpus | | | | | Yes | 17 (42.5) | | | | No | 23 (57.5) | | |
| | Vascular invasion | | | | | Yes | 20 (50.0) | | | | No | 20 (50.0) | | |
| | Lymph node invasion | | | | | Yes | 12 (30.0) | | | | No | 28 (70.0) | | |
| | Histologic type: | | Histologic type: | | | Endocervical NOS | 25 (62.5) | Endometrioid | 75 (81.5) | | Adenosquamous | 6 (15.0) | Adenosquamous | 4 (4.4) | | Endometrioid | 5 (12.5) | Clear cell | 5 (5.4) | | Serous | 1 (2.5) | Serous | 5 (5.4) | | “Mixed” | 2 (5.0) | “Mixed” | 3 (3.3) |
|
|
